
( (S 
    (NP-SBJ-1 
      (NP (DT A) (JJ new) (NN drug) )
      (SBAR 
        (WHNP-2 (-NONE- 0) )
        (S 
          (NP-SBJ (-NONE- *T*-2) )
          (VP (TO to) 
            (VP (VB prevent) 
              (NP 
                (NP (DT the) (NN rejection) )
                (PP (IN of) 
                  (NP (JJ transplanted) (NNS organs) ))))))))
    (VP (VBZ has) 
      (VP (VBN been) 
        (VP 
          (ADVP-MNR (RB successfully) )
          (VBN used) 
          (NP (-NONE- *-1) )
          (PP-CLR (IN on) 
            (NP 
              (QP (JJR more) (IN than) (CD 100) )
              (NNS patients) ))
          (PP-LOC (IN at) 
            (NP 
              (NP (DT the) (NNP University) )
              (PP (IN of) 
                (NP (NNP Pittsburgh) ))))
          (, ,) 
          (PP (VBG according) 
            (PP (TO to) 
              (NP (NNS researchers) ))))))
    (. .) ))
( (S 
    (S 
      (NP-SBJ-1 
        (NP (DT The) (NN drug) )
        (, ,) 
        (SBAR 
          (WHNP-2 (WDT which) )
          (S 
            (NP-SBJ (-NONE- *T*-2) )
            (VP (VBZ is) 
              (ADVP-TMP (RB still) )
              (PP-LOC-PRD (IN in) 
                (NP (DT the) (JJ experimental) (NN phase) )))))
        (, ,) )
      (VP (VBZ has) (RB n't) 
        (VP (VBN been) 
          (VP (VBN approved) 
            (NP (-NONE- *-1) )
            (ADVP-TMP (RB yet) )
            (PP (IN by) 
              (NP-LGS (DT the) (NNP Food) 
                (CC and)
                (NNP Drug) (NNP Admistration) ))))))
    (, ,) 
    (CC and)
    (S 
      (NP-SBJ (PRP$ its) (JJ long-term) (NNS effects) )
      (VP (VBP are) 
        (ADJP-PRD (JJ unknown) )))
    (. .) ))
( (S (CC But) 
    (NP-SBJ (NNS researchers) )
    (VP (VBP say) 
      (SBAR (-NONE- 0) 
        (S 
          (NP-SBJ 
            (NP (DT the) (NN drug) )
            (, ,) 
            (VP (VBN called) 
              (S 
                (NP-SBJ (-NONE- *) )
                (NP-PRD (NNP FK-506) )))
            (, ,) )
          (VP (MD could) 
            (VP (VB revolutionize) 
              (NP (DT the) (NN transplantation) (NN field) )
              (PP-MNR 
                (PP (IN by) 
                  (S-NOM 
                    (NP-SBJ (-NONE- *) )
                    (VP (VBG reducing) 
                      (NP (JJ harmful) (JJ side) (NNS effects) ))))
                (CC and) 
                (PP (IN by) 
                  (S-NOM 
                    (NP-SBJ (-NONE- *) )
                    (VP (VBG lowering) 
                      (NP (NN rejection) (NNS rates) ))))))))))
    (. .) ))
( (S 
    (NP-SBJ (NN Rejection) )
    (VP (VBZ has) 
      (VP (VBN been) 
        (NP-PRD (DT the) (JJ major) (NN obstacle) )
        (PP-LOC (IN in) 
          (NP 
            (NP (DT the) 
              (QP (RB approximately) (CD 30,000) )
              (NN organ) (NNS transplants) )
            (VP (VBN performed) 
              (NP (-NONE- *) )
              (ADVP-LOC (RB world-wide) )
              (NP-TMP (DT each) (NN year) ))))))
    (. .) ))
( (S 
    (NP-SBJ-2 (NNS Researchers) )
    (VP (VBD began) 
      (S 
        (NP-SBJ (-NONE- *-2) )
        (VP (VBG using) 
          (NP (DT the) (NN drug) )
          (PP-CLR (-NONE- *ICH*-3) )))
      (PP-TMP (IN in) 
        (NP (NNP February) ))
      (PP-CLR-3 (IN on) 
        (NP 
          (NP (NNS patients) )
          (SBAR 
            (WHNP-1 (WP who) )
            (S 
              (NP-SBJ (-NONE- *T*-1) )
              (VP (VBD had) 
                (VP (VBN received) 
                  (NP (NN kidney) 
                    (, ,)
                    (NN liver) 
                    (, ,)
                    (NN heart) 
                    (CC and)
                    (NN pancreas) (NNS transplants) ))))))))
    (. .) ))
( (S 
    (NP-SBJ-1 
      (QP (RB Only) (CD two) (IN of) (CD 111) )
      (NNS transplants) )
    (VP (VBP have) 
      (VP (VBN been) 
        (VP (VBN rejected) 
          (NP (-NONE- *-1) ))))
    (. .) ))
( (S 
    (NP-SBJ-1 
      (NP (DT The) (NN drug) )
      (, ,) 
      (VP (VBN discovered) 
        (NP (-NONE- *) )
        (PP-TMP (IN in) 
          (NP (CD 1984) )))
      (, ,) )
    (VP (VBZ is) 
      (VP (VBN metabolized) 
        (NP (-NONE- *-1) )
        (PP-CLR (IN from) 
          (NP 
            (NP (NN soil) (NN fungus) )
            (VP (VBN found) 
              (NP (-NONE- *) )
              (PP-TMP (IN in) 
                (NP (NNP Japan) )))))))
    (. .) ))
( (S 
    (NP-SBJ (DT The) (NNP Pittsburgh) (NNS patients) )
    (VP (VBP are) 
      (NP-PRD 
        (NP (DT the) (JJ first) (NNS humans) )
        (SBAR 
          (WHNP-4 (-NONE- 0) )
          (S 
            (NP-SBJ-1 (-NONE- *T*-4) )
            (VP (TO to) 
              (VP (VB be) 
                (VP (VBN given) 
                  (NP (-NONE- *-1) )
                  (NP 
                    (NP (DT the) (NN drug) )
                    (, ,) 
                    (SBAR 
                      (WHNP-3 (WDT which) )
                      (S 
                        (NP-SBJ-2 (-NONE- *T*-3) )
                        (VP (VBZ is) 
                          (VP (VBN made) 
                            (NP (-NONE- *-2) )
                            (PP (IN by) 
                              (NP-LGS (NNP Fujisawa) (NNP Pharmaceutical) (NNP Co) ))))))))))))))
    (. .) ))
( (SINV (`` ``) 
    (S-TPC-1 
      (NP-SBJ (PRP We) )
      (VP (VBP 're) 
        (VP (JJ shocked) 
          (PP (IN by) 
            (NP (PRP it) ))))
      (, ,) 
      (SBAR (IN because) 
        (S 
          (NP-SBJ (PRP it) )
          (VP (VBZ 's) 
            (VP (VBN worked) 
              (ADVP (RB so) (RB fast) ))))))
    (, ,) ('' '') 
    (VP (VBD said) 
      (S (-NONE- *T*-1) ))
    (NP-SBJ 
      (NP (NNP Dr.) (NNP Thomas) (NNP E.) (NNP Starzl) )
      (, ,) 
      (NP 
        (NP (NN director) )
        (PP (IN of) 
          (NP (DT the) 
            (NAC (NNP University) 
              (PP (IN of) 
                (NP (NNP Pittsburgh) )))
            (NNP Transplantation) (NNP Program) )))
      (, ,) )
    (PP-LOC (IN at) 
      (NP (DT a) (NN news) (NN conference) ))
    (ADVP-LOC (RB here) )
    (NP-TMP (NN yesterday) )
    (. .) ))
( (SINV (`` ``) 
    (S-TPC-1 
      (NP-SBJ (PRP We) )
      (VP (VBP consider) 
        (S 
          (NP-SBJ (PRP it) )
          (NP-PRD 
            (NP (DT a) (JJ life-saving) (NN drug) )
            (, ,) 
            (PP (IN like) 
              (NP 
                (NP (CD one) )
                (PP (IN for) 
                  (NP (NNP AIDS) ))))))))
    (, ,) ('' '') 
    (VP (VBD said) 
      (S (-NONE- *T*-1) ))
    (NP-SBJ 
      (NP (NNP Dr.) (NNP John) (NNP Fung) )
      (, ,) 
      (NP 
        (NP (DT an) (NN immunologist) )
        (PP-LOC (IN at) 
          (NP 
            (NP (DT the) (NNP University) )
            (PP (IN of) 
              (NP (NNP Pittsburgh) ))))))
    (. .) ))
( (S 
    (NP-SBJ (NNS Researchers) )
    (VP (VBP say) 
      (SBAR (-NONE- 0) 
        (S 
          (NP-SBJ (PRP they) )
          (VP (VBP believe) 
            (SBAR (-NONE- 0) 
              (S 
                (NP-SBJ (NNP FK-506) )
                (VP (VBZ is) 
                  (ADJP-PRD 
                    (ADJP 
                      (QP (CD 100) (NNS times) )
                      (RBR more) (JJ effective) )
                    (PP (IN than) 
                      (NP 
                        (NP (DT the) (JJ traditional) (JJ anti-rejection) (NN drug) )
                        (, ,) 
                        (NP (NN cyclosporine) )
                        (, ,) 
                        (VP (VBN made) 
                          (NP (-NONE- *) )
                          (PP (IN by) 
                            (NP-LGS (JJ Swiss) (JJ pharmaceutical) (NN giant) (NNP Sandoz) (NNP Ltd) )))))))))))))
    (. .) ))
( (S 
    (NP-SBJ-1 (PRP They) )
    (VP (VBP are) 
      (ADVP (RB also) )
      (VP (VBN encouraged) 
        (NP (-NONE- *-1) )
        (PP (IN by) 
          (NP-LGS 
            (NP (DT the) 
              (ADJP (RB relatively) (JJ mild) )
              (JJ side) (NNS effects) )
            (PP (IN of) 
              (NP (NNP FK-506) ))
            (, ,) 
            (PP (VBN compared) 
              (PP (IN with) 
                (NP 
                  (NP (NN cyclosporine) )
                  (, ,) 
                  (SBAR 
                    (WHNP-507 (WDT which) )
                    (S 
                      (NP-SBJ (-NONE- *T*-507) )
                      (VP (MD can) 
                        (VP (VB cause) 
                          (NP 
                            (NP (JJ renal) (NN failure) )
                            (, ,) 
                            (NP (NN morbidity) )
                            (, ,) 
                            (NP (NN nausea) )
                            (CC and) 
                            (NP (JJ other) (NNS problems) )))))))))))))
    (. .) ))
( (S (`` ``) 
    (S-1 
      (NP-SBJ 
        (NP (DT The) (JJ side) (NNS effects) )
        (PRN 
          (-LRB- -LCB-)
          (PP (IN of) 
            (NP (NN cyclosporine) ))
          (-RRB- -RCB-) ))
      (VP (VBP have) 
        (VP (VBN made) 
          (S 
            (NP-SBJ 
              (NP (DT the) (NN penalty) )
              (PP (IN for) 
                (NP (PRP$ its) (NN success) )))
            (ADJP-PRD (RB rather) (JJ high) )))))
    (, ,) ('' '') 
    (NP-SBJ (NNP Dr.) (NNP Starzl) )
    (VP (VBD said) 
      (S (-NONE- *T*-1) ))
    (. .) ))
( (S 
    (NP-SBJ (NNP Dr.) (NNP Fung) )
    (VP (VBD said) 
      (SBAR 
        (SBAR (IN that) 
          (S 
            (NP-SBJ (NNP FK-506) )
            (VP (MD would) (RB not) 
              (VP (VB be) 
                (ADJP-PRD (JJ available) )
                (PP-LOC (IN in) 
                  (NP (DT the) (NN market) ))
                (PP-TMP (IN for) 
                  (NP 
                    (QP (IN at) (JJS least) (DT a) )
                    (NN year) ))))))
        (, ,) 
        (CC and)
        (SBAR (IN that) 
          (S 
            (NP-SBJ (DT the) (NNP FDA) (NN approval) (NN process) )
            (ADVP-TMP (RB usually) )
            (VP (VBZ takes) 
              (NP 
                (NP (CD three) (NNS years) )
                (TO to) 
                (NP (CD five) (NNS years) )))))))
    (. .) ))
( (S 
    (NP-SBJ (EX There) )
    (VP (VBP are) 
      (NP-PRD (DT no) (JJ firm) (NNS plans) 
        (S 
          (NP-SBJ (-NONE- *) )
          (VP (TO to) 
            (VP (VB expand) 
              (NP (DT the) (JJ experimental) (NN program) )
              (PP-DIR-CLR (IN beyond) 
                (NP 
                  (NP 
                    (NP (DT the) (NNP University) )
                    (PP (IN of) 
                      (NP (NNP Pittsburgh) )))
                  (, ,) 
                  (SBAR 
                    (WHNP-1 (WP$ whose) (NN hospital) )
                    (S 
                      (NP-SBJ (-NONE- *T*-1) )
                      (VP (VBZ performs) 
                        (NP 
                          (NP (DT the) (JJS most) (NNS transplants) )
                          (PP-LOC (IN in) 
                            (NP (DT the) (NN world) )))))))))))))
    (. .) ))
( (S 
    (S 
      (NP-SBJ (NNS Researchers) )
      (VP (MD could) (RB n't) 
        (VP (VB estimate) 
          (NP 
            (NP (DT the) (NN cost) )
            (PP (IN of) 
              (NP (DT the) (NN drug) ))
            (SBAR 
              (WHADVP-1 (WRB when) )
              (S 
                (NP-SBJ (PRP it) )
                (VP (VBZ reaches) 
                  (NP (DT the) (NN market) )
                  (ADVP-TMP (-NONE- *T*-1) ))))))))
    (, ,) (CC but) 
    (S 
      (NP-SBJ (PRP they) )
      (VP (VBD said) 
        (SBAR (-NONE- 0) 
          (S 
            (NP-SBJ (NNP FK-506) )
            (VP (MD will) 
              (VP 
                (VP (VB enable) 
                  (S 
                    (NP-SBJ (NNS patients) )
                    (VP (TO to) 
                      (VP (VB cut) 
                        (NP (NN hospital) (NNS stays) )
                        (PP-EXT (IN by) 
                          (NP (CD 50) (NN %) ))))))
                (CC and) 
                (VP (VB reduce) 
                  (NP 
                    (NP (DT the) (NN number) )
                    (PP (IN of) 
                      (NP 
                        (NP (NN blood) (NNS tests) )
                        (VP (VBN used) 
                          (S-CLR 
                            (NP-SBJ (-NONE- *) )
                            (VP (TO to) 
                              (VP (VB monitor) 
                                (NP 
                                  (NP (DT the) (NN dosage) )
                                  (PP (IN of) 
                                    (NP 
                                      (NP (JJ cyclosporine) )
                                      (CC and) 
                                      (NP (JJ other) (NNS drugs) )))))))
                          (PP-LOC (IN among) 
                            (NP (NN transplant) (NNS recipients) )))))))))))))
    (. .) ))
( (S 
    (NP-SBJ (NNP Dr.) (NNP Starzl) )
    (VP (VBD said) 
      (SBAR 
        (SBAR (-NONE- 0) 
          (S 
            (NP-SBJ-1 (DT the) (NN research) )
            (VP (VBZ has) 
              (VP (VBN been) 
                (ADVP (RB largely) )
                (VP (VBN financed) 
                  (NP (-NONE- *-1) )
                  (PP 
                    (PP (IN by) 
                      (NP-LGS 
                        (NP (DT the) (NNP National) (NNP Institute) )
                        (PP (IN of) 
                          (NP (NNP Health) ))))
                    (CC and) 
                    (PP (IN by) 
                      (NP-LGS (NN university) (NNS funds) ))))))))
        (, ,) 
        (CC and)
        (SBAR (IN that) 
          (S 
            (NP-SBJ (NNP Fujisawa) )
            (VP (VBD did) (RB n't) 
              (VP (VB give) 
                (NP (DT the) (NN hospital) )
                (NP (DT any) (NNS grants) )))))))
    (. .) ))
( (S 
    (NP-SBJ (PRP He) )
    (VP (VBD said) 
      (SBAR (IN that) 
        (S 
          (NP-SBJ (DT the) (NN research) (NN team) )
          (VP (VBD had) 
            (NP 
              (NP (DT no) (JJ financial) (NN stake) )
              (PP-LOC (IN in) 
                (NP (DT the) (NN drug) )))))))
    (. .) ))
( (S (`` ``) 
    (S-TPC-2 
      (S 
        (NP-SBJ (PRP We) )
        (VP (VBP 've) 
          (VP (VBN known) 
            (PP-TMP (IN for) 
              (NP (CD six) (NNS months) ))
            (NP 
              (NP (DT the) (NN effect) )
              (PP (IN of) 
                (NP (DT this) (NN drug) ))))))
      (, ,) 
      (CC and)
      (S 
        (NP-SBJ 
          (NP (PRP$ our) (NN advice) )
          (PP (TO to) 
            (NP (PRP$ our) (NNS people) )))
        (VP (VBZ has) 
          (VP (VBN been) 
            (S-PRD 
              (NP-SBJ (-NONE- *) )
              (RB not) 
              (VP (TO to) 
                (VP (VB buy) 
                  (NP 
                    (NP (DT the) (NN company) (POS 's) )
                    (NN stock) ))))))))
    (, ,) ('' '') 
    (NP-SBJ-1 (NNP Dr.) (NNP Starzl) )
    (VP (VBD said) 
      (S (-NONE- *T*-2) )
      (, ,) 
      (S-ADV 
        (NP-SBJ (-NONE- *-1) )
        (VP (VBG adding) 
          (SBAR (IN that) 
            (S 
              (S-NOM-SBJ 
                (NP-SBJ (-NONE- *) )
                (VP (VBG profiting) 
                  (PP-CLR (IN from) 
                    (NP (NNP FK-506) ))))
              (VP (MD would) (RB n't) 
                (VP (VB be) 
                  (ADJP-PRD (JJ ethical) ))))))))
    (. .) ))
